Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Acrivon Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- +1 vs. Q2 2024
- Shares held
- 23.0M
- +275.9K (+1.2%) vs. Q2 2024
- Total value
- $160.8M
- +$29.2M (+22.2%) vs. Q2 2024
- New holders
- 8
- 17 more added
- Sold out
- 7
- 14 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,340,508 | $58.4M | 0.67% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 5,360,858 | $37.5M | 0.81% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,140,628 | $15.0M | 0.02% | +20,982+1.0% | Added |
| Sands Capital Ventures, LLC | 2,122,605 | $14.9M | 4.18% | 00.0% | Unchanged |
| Wellington Management Group LLP | 888,130 | $6.22M | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 809,859 | $5.67M | 0.01% | −139,007−14.6% | Reduced |
| BlackRock, Inc. | 786,982 | $5.51M | 0.00% | +786,982 | New |
| Vanguard Group Inc | 637,538 | $4.46M | 0.00% | −107,972−14.5% | Reduced |
| Geode Capital Management, LLC | 302,103 | $2.12M | 0.00% | −6,290−2.0% | Reduced |
| State Street Corp | 225,896 | $1.58M | 0.00% | +47,233+26.4% | Added |
| Goldman Sachs Group Inc | 198,168 | $1.39M | 0.00% | +173,784+712.7% | Added |
| Exome Asset Management LLC | 116,757 | $817.3K | 0.55% | +116,757 | New |
| Charles Schwab Investment Management Inc | 116,253 | $813.8K | 0.00% | −27,705−19.2% | Reduced |
| DAFNA Capital Management LLC | 112,414 | $786.9K | 0.19% | −8,937−7.4% | Reduced |
| Northern Trust Corp | 105,398 | $737.8K | 0.00% | −8,655−7.6% | Reduced |
| UBS Oconnor LLC | 79,249 | $554.7K | 0.01% | −26,000−24.7% | Reduced |
| Bridgeway Capital Management, LLC | 76,981 | $538.9K | 0.01% | +18,800+32.3% | Added |
| Baker Bros. Advisors LP | 52,885 | $370.2K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 45,900 | $321.3K | 0.00% | −8,600−15.8% | Reduced |
| Millennium Management LLC | 39,750 | $278.3K | 0.00% | +39,750 | New |
| Prelude Capital Management, LLC | 37,727 | $264.1K | 0.02% | +37,727 | New |
| Morgan Stanley | 35,914 | $251.4K | 0.00% | +18,665+108.2% | Added |
| JPMorgan Chase & Co | 33,991 | $237.9K | 0.00% | +28,748+548.3% | Added |
| Barclays PLC | 33,306 | $233.1K | 0.00% | +11,273+51.2% | Added |
| Dimensional Fund Advisors LP | 30,824 | $215.8K | 0.00% | +20,758+206.2% | Added |
| Trexquant Investment LP | 30,383 | $212.7K | 0.00% | +30,383 | New |
| Bank of America Corp | 29,963 | $209.7K | 0.00% | +2,413+8.8% | Added |
| Bank of New York Mellon Corp | 29,509 | $206.6K | 0.00% | −7,123−19.4% | Reduced |
| Nuveen Asset Management, LLC | 25,779 | $180.5K | 0.00% | +13,958+118.1% | Added |
| Exchange Traded Concepts, LLC | 20,348 | $142.4K | 0.00% | −22,516−52.5% | Reduced |
| Rhumbline Advisers | 17,760 | $124.3K | 0.00% | +1,551+9.6% | Added |
| American Century Companies Inc | 15,402 | $107.8K | 0.00% | +15,402 | New |
| Marex Group plc | 13,187 | $92.3K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 11,216 | $78.5K | 0.00% | +6,134+120.7% | Added |
| AAFCPAs Wealth Management, LLC | 10,678 | $74.7K | 0.04% | 00.0% | Unchanged |
| Mirae Asset Global ETFs Holdings Ltd. | 6,471 | $45.3K | 0.00% | −37−0.6% | Reduced |
| Corebridge Financial, Inc. | 6,316 | $44.2K | 0.00% | −39−0.6% | Reduced |
| UBS Group AG | 5,662 | $39.6K | 0.00% | −5,490−49.2% | Reduced |
| Wells Fargo & Company | 5,422 | $38.0K | 0.00% | +231+4.5% | Added |
| Tower Research Capital LLC (TRC) | 4,755 | $33.3K | 0.00% | +976+25.8% | Added |
| FMR LLC | 2,581 | $18.1K | 0.00% | +933+56.6% | Added |
| New York State Common Retirement Fund | 2,314 | $16.2K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,277 | $9.00K | 0.00% | +161+14.4% | Added |
| California State Teachers Retirement System | 856 | $5.99K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 839 | $5.87K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 800 | $5.60K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 695 | $4.87K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 378 | $3.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 400 | $2.80K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 258 | $1.81K | 0.00% | −911−77.9% | Reduced |
| Sterling Capital Management LLC | 37 | $259 | 0.00% | +37 | New |
| Capital Performance Advisors LLP | 32 | $224 | 0.00% | +32 | New |
| CWM, LLC | 46 | $0 | 0.00% | +23+100.0% | Added |
| Capital Advisors, Ltd. LLC | 48 | $0 | 0.00% | 00.0% | Unchanged |
| Avion Wealth | 88 | $0 | 0.00% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −659,724−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −30,714−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −17,207−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −12,721−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −12,552−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,493−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −5,080−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |